APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 93 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,532,000 | +59.7% | 78,549 | +8.0% | 0.00% | +100.0% |
| Q4 2018 | $959,000 | -62.9% | 72,723 | -50.0% | 0.00% | -50.0% |
| Q3 2018 | $2,586,000 | +70.4% | 145,446 | +110.8% | 0.00% | 0.0% |
| Q2 2018 | $1,518,000 | +296.3% | 69,007 | +298.6% | 0.00% | – |
| Q1 2018 | $383,000 | +41.9% | 17,311 | +39.2% | 0.00% | – |
| Q4 2017 | $270,000 | – | 12,435 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |